These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1979910)
1. Polyionic compounds selectively alter availability of CD4 receptors for HIV coat protein rgp120. Weaver JL; Gergely P; Pine PS; Patzer E; Aszalos A AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1125-30. PubMed ID: 1979910 [TBL] [Abstract][Full Text] [Related]
2. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. Lederman S; Gulick R; Chess L J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782 [TBL] [Abstract][Full Text] [Related]
3. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Schols D; Pauwels R; Desmyter J; De Clercq E Virology; 1990 Apr; 175(2):556-61. PubMed ID: 1691563 [TBL] [Abstract][Full Text] [Related]
4. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Schols D; Baba M; Pauwels R; Desmyter J; De Clercq E Proc Natl Acad Sci U S A; 1989 May; 86(9):3322-6. PubMed ID: 2566170 [TBL] [Abstract][Full Text] [Related]
5. Detection of T cell CD4 epitopes in HIV-infected individuals. Kunkl A; Valle MT; Fenoglio D; Dodi F; Morandi N; Rizzo F; Manca F Eur J Histochem; 1994; 38 Suppl 1():41-6. PubMed ID: 8547709 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of HSV-1-specific cytotoxic T lymphocytes by recombinant-derived gp120 of HIV-1. Schmid DS; Thieme ML; Ridgeway MR; Mawle AC Viral Immunol; 1992; 5(4):249-56. PubMed ID: 1361737 [TBL] [Abstract][Full Text] [Related]
7. Aurin tricarboxylic acid, the anti-AIDS compound, prevents the binding of interferon-alpha to its receptor. Gan YX; Weaver JL; Pine PS; Zoon KC; Aszalos A Biochem Biophys Res Commun; 1990 Nov; 172(3):1298-303. PubMed ID: 2147104 [TBL] [Abstract][Full Text] [Related]
8. Neutralization of HIV-1 by anti-idiotypes to monoclonal anti-CD4. Potential for idiotype immunization against HIV. Sutor GC; Dreikhausen U; Vähning U; Jurkiewicz E; Hunsmann G; Lundin K; Schedel I J Immunol; 1992 Aug; 149(4):1452-61. PubMed ID: 1500724 [TBL] [Abstract][Full Text] [Related]
9. Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations. Tuosto L; Gilardini Montani MS; Lorenzetti S; Cundari E; Moretti S; Lombardi G; Piccolella E Eur J Immunol; 1995 Oct; 25(10):2907-16. PubMed ID: 7589091 [TBL] [Abstract][Full Text] [Related]
10. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination. Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839 [TBL] [Abstract][Full Text] [Related]
11. Sulfated polyester interactions with the CD4 molecule and with the third variable loop domain (v3) of gp120 are chemically distinct. Lederman S; Bergmann JE; Cleary AM; Yellin MJ; Fusco PJ; Chess L AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1599-610. PubMed ID: 1457206 [TBL] [Abstract][Full Text] [Related]
12. A fungal metabolite which inhibits the interaction of CD4 with major histocompatibility complex-encoded class II molecules. Gammon G; Chandler G; Depledge P; Elcock C; Wrigley S; Moore J; Cammarota G; Sinigaglia F; Moore M Eur J Immunol; 1994 Apr; 24(4):991-8. PubMed ID: 8149967 [TBL] [Abstract][Full Text] [Related]
13. A polyanion binding site on the CD4 molecule. Proximity to the HIV-gp120 binding region. Parish CR; Low L; Warren HS; Cunningham AL J Immunol; 1990 Aug; 145(4):1188-95. PubMed ID: 2380554 [TBL] [Abstract][Full Text] [Related]
14. Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells. Corbeil J; Richman DD J Gen Virol; 1995 Mar; 76 ( Pt 3)():681-90. PubMed ID: 7897356 [TBL] [Abstract][Full Text] [Related]
15. Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection. Lynch G; Low L; Li S; Sloane A; Adams S; Parish C; Kemp B; Cunningham AL J Leukoc Biol; 1994 Sep; 56(3):266-72. PubMed ID: 7521897 [TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity. Konopka K; Pretzer E; Celada F; Düzgüneş N J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355 [TBL] [Abstract][Full Text] [Related]
17. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins. Jansen RW; Molema G; Pauwels R; Schols D; De Clercq E; Meijer DK Mol Pharmacol; 1991 Jun; 39(6):818-23. PubMed ID: 2051994 [TBL] [Abstract][Full Text] [Related]
18. The orientation of HIV-1 gp120 binding to the CD4 receptor differentially modulates CD4+ T cell activation. Zimmermann K; Liechti T; Haas A; Rehr M; Trkola A; Günthard HF; Oxenius A J Immunol; 2015 Jan; 194(2):637-49. PubMed ID: 25472996 [TBL] [Abstract][Full Text] [Related]
19. CD4-binding compounds: an assay to detect new classes of immunopharmacological agents. Chandler G; Elcock C; Depledge P; Wrigley S; Mous J; Malkovsky M; Moore M; Gammon G Int J Immunopharmacol; 1993 Apr; 15(3):361-9. PubMed ID: 8505149 [TBL] [Abstract][Full Text] [Related]
20. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients. Amadori A; De Silvestro G; Zamarchi R; Veronese ML; Mazza MR; Schiavo G; Panozzo M; De Rossi A; Ometto L; Mous J J Immunol; 1992 May; 148(9):2709-16. PubMed ID: 1374095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]